过敏免疫疗法市场规模、份额、成长分析，按治疗类型、过敏类型、分销管道、地区 - 行业预测，2024-2031

2022年全球过敏免疫治疗市场规模将为20.7亿美元，从2023年的22.6亿美元增长到2031年的45亿美元，预计在预测期内（2024-2031年）复合年增长率为9.0%。

全球过敏免疫治疗市场按治疗方法、过敏类型、分销管道和地区细分。治疗方法包括使用锭剂和滴剂的皮下免疫疗法（SCIT）和舌下免疫疗法（SLIT），过敏性疾病包括过敏性鼻炎和过敏性气喘。透过线上平台和医院、零售药局等线下场所进行分销，市场遍及北美、欧洲、亚太、中东和非洲以及拉丁美洲。据估计，世界上有 10-30% 的人口患有各种过敏症，对免疫疗法的需求正在增加。促进市场扩张的因素包括工业成长、医疗保健的进步以及由口腔溶解片等创新产品的监管核准推动的新治疗方法的推出。

目录

介绍

• 研究目的
• 调查范围
• 定义

调查方法

• 资讯采购
• 二手资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制因素和挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2023）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 价格分析
• 技术进步

过敏免疫治疗市场规模：依治疗类型及复合年增长率（2024-2031）

• 市场概况
• 皮下免疫治疗
• 舌下免疫治疗

按类型分類的过敏免疫治疗市场规模和复合年增长率（2024-2031）

• 市场概况
• 药片
• 降低

过敏免疫治疗市场规模：依过敏类型及复合年增长率（2024-2031）

• 市场概况
• 过敏性鼻炎
• 过敏性气喘
• 其他的

过敏免疫治疗市场规模：按分销管道和复合年增长率（2024-2031）

• 市场概况
• 医院药房
• 零售药房
• 网路药房

过敏免疫治疗市场规模及复合年增长率（2024-2031）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争资讯

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2023）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2021-2023）

主要企业简介

• ALK-Abello
• Allergy Therapeutics
• Anergis SA
• ASIT biotech
• DBV Technologies
• HAL Allergy Group
• Hymenoptera Immunotherapy Group
• Immunomic Therapeutics, Inc.
• Laboratorios LETI
• Merck KGaA
• Novartis International AG
• Stallergenes Greer plc
• Tunitas Therapeutics, Inc.
• VentiRx Pharmaceuticals
• Biomay AG
• Genentech, Inc.
• GlaxoSmithKline plc
• Meda AB
• Pfizer Inc.
• Regeneron Pharmaceuticals, Inc.

结论和建议

Global Allergy Immunotherapy Market size was valued at USD 2.07 billion in 2022 and is poised to grow from USD 2.26 billion in 2023 to USD 4.5 billion by 2031, growing at a CAGR of 9.0% during the forecast period (2024-2031).

The global Allergy Immunotherapy Market is categorized by treatment methods, types of allergies, distribution channels, and geographical regions. Treatment options include Subcutaneous Immunotherapy (SCIT) and Sublingual Immunotherapy (SLIT) through tablets and drops, while allergic conditions encompass allergic rhinitis, allergic asthma, and others. Distribution occurs through online platforms and offline venues, including hospital and retail pharmacies, and the market spans North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. With an estimated 10-30% of the global population affected by various allergies, the demand for immunotherapy is growing. Factors driving market expansion include industrial growth, advancements in healthcare, and the introduction of new therapies, bolstered by regulatory approvals for innovative products like oral dissolvable tablets.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Allergy Immunotherapy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Allergy Immunotherapy Market Segmental Analysis

Global Allergy Immunotherapy Market is segmented by treatment type, type, allergy type, distribution channel and region. Based on treatment type, the market is segmented into subcutaneous immunotherapy and sublingual immunotherapy. Based on type, the market is segmented into tablets and drops. Based on allergy type, the market is segmented into allergic rhinitis, allergic asthma and others. Based on distribution channel, the market is segmented into hospital pharmacy, retail pharmacy and online pharmacy. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Allergy Immunotherapy Market

The Global Allergy Immunotherapy market is primarily driven by the escalating incidence of allergies, which has created a pressing need for effective treatment options. The increasing cases of various allergies, along with the advent of novel sublingual immunotherapies, particularly in developing countries, are significantly propelling market growth. In the U.S., allergies rank as the sixth most prevalent chronic condition, impacting over 50 million individuals and incurring annual costs exceeding USD 18 billion, according to the American College of Allergy, Asthma & Immunology. Furthermore, the rising prevalence of food allergies among both children and adults worldwide is anticipated to further boost the demand for advanced immunotherapy solutions.

Restraints in the Global Allergy Immunotherapy Market

The global allergy immunotherapy market faces significant challenges due to several restraints. Primarily, the cutting-edge technology employed in allergy immunotherapy necessitates regular maintenance, which demands specialized professional expertise, thereby driving up routine maintenance costs. As a result, operational expenses are expected to increase, posing a substantial hurdle to market growth. Furthermore, there is a pressing need to enhance awareness and understanding of this advanced therapeutic approach across various sectors. The lack of familiarity with innovative technological advancements may act as an additional barrier to the market's development, hindering its potential expansion and limiting patient access to effective treatments.

Market Trends of the Global Allergy Immunotherapy Market

The Global Allergy Immunotherapy market is witnessing a significant upward trend driven by advancements in technology, particularly in high-resolution analysis of rare cells within local tissues. These innovations have facilitated the identification of precise and reliable biomarkers for monitoring allergy immunotherapy, enhancing treatment efficacy and personalizing patient care. As healthcare providers increasingly adopt these cutting-edge analytical techniques, the market is expected to expand rapidly, fostering the development of targeted therapies and improving patient compliance. Additionally, the growing prevalence of allergic conditions and rising awareness regarding effective treatment options further bolster market growth, positioning allergy immunotherapy as a vital component of modern allergy management strategies.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement

Global Allergy Immunotherapy Market Size by Treatment Type & CAGR (2024-2031)

• Market Overview
• Subcutaneous Immunotherapy
• Sublingual Immunotherapy

Global Allergy Immunotherapy Market Size by Type & CAGR (2024-2031)

• Market Overview
• Tablets
• Drops

Global Allergy Immunotherapy Market Size by Allergy Type & CAGR (2024-2031)

• Market Overview
• Allergic Rhinitis
• Allergic Asthma
• Others

Global Allergy Immunotherapy Market Size by Distribution Channel & CAGR (2024-2031)

• Market Overview
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

Global Allergy Immunotherapy Market Size & CAGR (2024-2031)

• North America (Treatment Type, Type, Allergy Type, Distribution Channel)
  • USA
  • Canada
• Europe (Treatment Type, Type, Allergy Type, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Treatment Type, Type, Allergy Type, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Treatment Type, Type, Allergy Type, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Treatment Type, Type, Allergy Type, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• ALK-Abello
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allergy Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Anergis SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ASIT biotech
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DBV Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HAL Allergy Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hymenoptera Immunotherapy Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Immunomic Therapeutics, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Laboratorios LETI
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis International AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stallergenes Greer plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tunitas Therapeutics, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VentiRx Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biomay AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genentech, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meda AB
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Regeneron Pharmaceuticals, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations